Cardamomin protects from diabetes-induced kidney damage through modulating PI3K/AKT and JAK/STAT signaling pathways

Chan Gao1, Xiao Fei1, Ming Wang1

  • 1Departmemt of Nephrology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine. Hangzhou, Zhejiang 310000, PR China.

Abstract

Insights

Cardamonin (CAD) protects against diabetic kidney damage by reducing inflammation and oxidative stress. It modulates key signaling pathways, offering a potential therapeutic strategy for diabetic nephropathy.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic nephropathy is a severe complication of diabetes mellitus, impacting patient quality of life.
  • Investigating protective agents against diabetes-induced kidney damage is crucial.

Purpose of the Study:

  • To investigate the protective effects of cardamonin (CAD) on diabetes-induced kidney damage in a rat model.
  • To elucidate the underlying molecular mechanisms of CAD's action.

Main Methods:

  • Utilized methylglyoxal (MGO) and streptozotocin (STZ) to induce kidney damage in rat kidney cells (NRK-52E) and rats, respectively.
  • Assessed cell viability, proliferation, migration, and apoptosis using MTT, EdU, Transwell, and flow cytometry.
  • Analyzed protein expression (AGEs, RAGE, EMT, PI3K/AKT, JAK/STAT3), inflammatory cytokines (TNF-α, IL-6, IL-1β), oxidative stress markers (MDA, GSH, SOD), and kidney pathology.

Main Results:

  • CAD treatment inhibited MGO-induced apoptosis, migration, and enhanced proliferation in NRK-52E cells.
  • CAD reduced advanced glycation end-products (AGEs), receptor for AGEs (RAGE), inflammatory cytokines, and oxidative stress markers in vitro and in vivo.
  • CAD attenuated epithelial-mesenchymal transition (EMT) and suppressed PI3K/AKT and JAK/STAT3 signaling pathways.

Conclusions:

  • Cardamonin (CAD) demonstrates significant protective effects against diabetes-induced kidney damage.
  • CAD exerts its protective functions by modulating PI3K/AKT and JAK/STAT signaling pathways, reducing inflammation and oxidative stress.

Related Concept Videos

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
279
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
519
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
547
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
842
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
70
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K